DOT1L promotes expression of CD44 through the Wnt/β-catenin signaling pathway in early gastric carcinoma.

J Cancer · 2024 · PMC10937288 · PMID 38495505

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In the EGC group, CD44, DOT1L and CTNNB1 showed a decreasing trend.

also in 47,180 other papers

showed a trendno p-value reported

In the LGIN group, CD44, DOT1L and CTNNB1 showed a trend of first decreasing and then increasing.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.